// App-Quantinova.ai

: HCK Inhibition Displays Antineoplastic Activity on Acute Leukemia and Promotes Immune Regulation of the Bone Marrow Tumor Microenvironment

Researchers

Presenter

  • Fernanda Marconi Roversi

Principal Investigators

  • Maura Lima Pereira Bueno

  • Audrey Basso

  • Adriana Silva Santos Duarte

  • Juliete A.F. Silva

  • Sara T Olalla Saad

Medical Centers

  • Hematology and Hemotherapy Center, University of Campinas, Campinas, Brazil

  • Department of Surgery Division of Transplantation, Emory University, Atlanta, Georgia, United State, Atlanta, GA

  • Hematology and Transfusion Medicine Center- University of Campinas/Hemocentro-UNICAMP, Campinas, São Paulo, Brazil

Locations

  • Brazil

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Acute lymphoblastic leukemia

  • Alpha-thalassemia myelodysplasia syndrome

  • Chronic Myelogenous Leukemia

  • Acute Leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved